Medigene Ag MDGEF

$0.10 0.00 (—)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
10,000
Avg volume
—
Day's range
$0.10 – $0.10
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany.

Industry
Biotechnology
Sector
Healthcare
Phone
49 89 2000 330
Website
https://www.medigene.com
Address
Lochhamer Strasse 11, Planegg/Martinsried, Munich, Germany

Latest news

No headlines yet.